Global Pharmatech, Inc. Stock

Stocks

GBLP

US37945N1090

OTC Markets Traded
Market Closed - 03:59:56 06/06/2026 HKT 5-day change 1st Jan Change
0.0801 USD +60.18% Intraday chart for Global Pharmatech, Inc. +0.01% +60.20%
1 week+0.01%
Current month+0.01%

Valuation: Global Pharmatech, Inc.

Market Cap 4.72M 4.23M 3.89M 3.53M 6.59M 448M 6.71M 46.4M 18.63M 236M 17.72M 17.35M 744M P/E 2006
-20.5x
P/E 2007 -4.23x
Enterprise Value 2.04M 1.83M 1.68M 1.52M 2.85M 194M 2.9M 20.06M 8.05M 102M 7.66M 7.5M 322M EV / Sales 2006
11.5x
EV / Sales 2007 4.95x
Free-Float
-
Yield 2006 *
-
Yield 2007 -
1 day+60.18%
1 week+0.01%
Current month+0.01%
1 month+0.01%
3 months+0.01%
6 months+60.20%
Current year+60.20%
Current year 0.05
Extreme 0.05
0.08
1 year 0.05
Extreme 0.05
0.08
3 years 0.05
Extreme 0.05
0.35
5 years 0.05
Extreme 0.05
0.6
10 years 0.01
Extreme 0.008
0.9
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member - -

Financials

2006 2007
Net sales 2.38M 2.13M 1.96M 1.77M 3.31M 226M 3.38M 23.34M 9.37M 119M 8.92M 8.73M 374M 2.82M 2.52M 2.32M 2.1M 3.93M 268M 4.01M 27.69M 11.12M 141M 10.58M 10.35M 444M
Net income -1.23M -1.11M -1.02M -921K -1.72M -117M -1.75M -12.13M -4.87M -61.65M -4.63M -4.53M -194M -3.3M -2.95M -2.72M -2.46M -4.6M -313M -4.69M -32.41M -13.01M -165M -12.38M -12.12M -520M
Net Debt -2.68 -2.4 -2.21 -2 -3.74 -254.32 -3.81 -26.31 -10.56 -133.78 -10.05 -9.84 -421.9 -2.68 -2.4 -2.21 -2 -3.74 -254.58 -3.81 -26.34 -10.57 -133.92 -10.06 -9.85 -422.32
Logo Global Pharmatech, Inc.
Global Pharmatech Inc is a company primarily engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, traditional Chinese medicine (TCM) and dietary supplements. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The Company is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The Company also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The Company conducts its business in the domestic and overseas markets.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GBLP Stock